Related Experiment Video
Updated: Jul 17, 2026

A Novel In Vitro Live-imaging Assay of Astrocyte-mediated Phagocytosis Using pH Indicator-conjugated Synaptosomes
Published on: February 5, 2018
Pro-inflammatory conditions promote neuronal damage mediated by Amyloid Precursor Protein and decrease its
Rommy von Bernhardi1, Gigliola Ramírez, Rodrigo Toro
1Department of Neurology, Faculty of Medicine, Pontificia Universidad Católica de Chile Marcoleta 391, Santiago, Chile. rvonb@med.puc.cl
Abstract:
Aberrant handling of Amyloid Precursor Protein (APP) and beta-amyloid (Abeta), glial activation and inflammation are key events in Alzheimer's disease. We set out to determine the role of inflammation on microglial reactivity against APP. We studied microglia-mediated neurotoxicity, uptake and degradation of a biotinylated APP construct (biotin-APP-C-244). APP, in contrast to Abeta, only induced mild activation of glial cells. However, under pro-inflammatory conditions, APP induced microglial-mediated cytotoxicity. Biotin-APP-C-244 or lipopolysaccharide and interferon-gamma (LPS+IFNgamma), administered separately, did not change reduction metabolism of microglia. However, biotin-APP-C-244+(LPS+IFNgamma) increased microglial reactivity and decreased reduction metabolism by 75% (P<0.001). Biotin-APP-C-244 was readily taken up by microglial cells; 80% was phagocytosed at 2 h. In the presence of LPS+IFNgamma, phagocytosis of biotin-APP-C-244 was reduced at 2 h; and cell damage was evident after 4 h. Our results support our hypothesis that, in neuroinflammation, microglial scavenger function is impaired and reactivity against APP enhanced as an initial step for neurodegeneration.
Insights
Inflammation impairs microglial cells' ability to clear amyloid precursor protein (APP), increasing their reactivity and neurotoxicity. This suggests impaired scavenger function in neuroinflammation is an early step in Alzheimer's disease pathogenesis.
Area of Science:
- Neuroscience
- Cell Biology
- Pathology
Background:
- Alzheimer's disease (AD) involves abnormal amyloid precursor protein (APP) processing, beta-amyloid (Abeta) aggregation, glial activation, and neuroinflammation.
- Microglial cells, the brain's immune cells, play a critical role in AD pathogenesis.
Purpose of the Study:
- To investigate the impact of pro-inflammatory conditions on microglial reactivity and function concerning APP.
- To determine if inflammation exacerbates microglial-mediated neurotoxicity against APP.
Main Methods:
- Utilized a biotinylated APP construct (biotin-APP-C-244) to study microglial uptake, degradation, and cytotoxicity.
- Exposed microglia to APP alone, pro-inflammatory stimuli (lipopolysaccharide + interferon-gamma [LPS+IFNgamma]) alone, or in combination.
- Assessed microglial reduction metabolism and phagocytic activity.
Main Results:
- APP alone induced mild microglial activation, but combined with LPS+IFNgamma, it caused significant microglial cytotoxicity.
- Pro-inflammatory conditions (LPS+IFNgamma) combined with biotin-APP-C-244 exposure led to a 75% decrease in microglial reduction metabolism.
- While microglia readily phagocytosed biotin-APP-C-244, this process was inhibited by LPS+IFNgamma, preceding observable cell damage.
Conclusions:
- Neuroinflammation impairs microglial scavenger function, leading to enhanced microglial reactivity towards APP.
- This impaired clearance and heightened reactivity represent a potential early mechanism driving neurodegeneration in Alzheimer's disease.
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Alzheimer Disease ll: Pathophysiology
Bacterial Meningitis II: Pathophysiology
Encephalitis ll: Pathophysiology
Phagocytosis of Apoptotic Cells
Normal cells contain receptors that prevent them from being recognized by phagocytes.

